Annual EBIT
-$22.24 M
+$17.40 M+43.90%
December 31, 2023
Summary
- As of February 7, 2025, ATNF annual earnings before interest & taxes is -$22.24 million, with the most recent change of +$17.40 million (+43.90%) on December 31, 2023.
- During the last 3 years, ATNF annual EBIT has fallen by -$12.42 million (-126.53%).
- ATNF annual EBIT is now -126.53% below its all-time high of -$9.82 million, reached on December 31, 2020.
Performance
ATNF EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$823.10 K
-$846.20 K-3663.20%
September 30, 2024
Summary
- As of February 7, 2025, ATNF quarterly earnings before interest & taxes is -$823.10 thousand, with the most recent change of -$846.20 thousand (-3663.20%) on September 30, 2024.
- Over the past year, ATNF quarterly EBIT has increased by +$230.20 thousand (+21.86%).
- ATNF quarterly EBIT is now -104.50% below its all-time high of $18.31 million, reached on September 30, 2021.
Performance
ATNF Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$3.07 M
+$11.78 M+79.30%
September 30, 2024
Summary
- As of February 7, 2025, ATNF TTM earnings before interest & taxes is -$3.07 million, with the most recent change of +$11.78 million (+79.30%) on September 30, 2024.
- Over the past year, ATNF TTM EBIT has increased by +$15.47 million (+83.42%).
- ATNF TTM EBIT is now -112.88% below its all-time high of $23.87 million, reached on June 30, 2022.
Performance
ATNF TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ATNF EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.9% | +21.9% | +83.4% |
| 3 y3 years | -126.5% | +82.7% | +93.3% |
| 5 y5 years | +11.8% | +82.7% | +93.3% |
ATNF EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.3% | +43.9% | -127.9% | +96.4% | -112.9% | +94.2% |
| 5 y | 5-year | -126.5% | +43.9% | -104.5% | +96.8% | -112.9% | +94.2% |
| alltime | all time | -126.5% | +43.9% | -104.5% | +96.8% | -112.9% | +94.2% |
180 Life Sciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$823.10 K(-3663.2%) | -$3.07 M(-79.3%) |
| Jun 2024 | - | $23.10 K(-102.2%) | -$14.85 M(-19.9%) |
| Mar 2024 | - | -$1.05 M(-13.8%) | -$18.54 M(-16.6%) |
| Dec 2023 | -$22.24 M(-43.9%) | -$1.22 M(-90.3%) | -$22.24 M(-49.1%) |
| Sep 2023 | - | -$12.60 M(+243.4%) | -$43.70 M(-16.9%) |
| Jun 2023 | - | -$3.67 M(-22.8%) | -$52.58 M(+14.4%) |
| Mar 2023 | - | -$4.75 M(-79.1%) | -$45.96 M(+15.9%) |
| Dec 2022 | -$39.64 M(+96.6%) | -$22.68 M(+5.6%) | -$39.64 M(+149.0%) |
| Sep 2022 | - | -$21.48 M(-828.5%) | -$15.92 M(-166.7%) |
| Jun 2022 | - | $2.95 M(+87.7%) | $23.87 M(-1049.8%) |
| Mar 2022 | - | $1.57 M(+50.6%) | -$2.51 M(-87.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$20.16 M(+105.4%) | $1.04 M(-94.3%) | -$20.16 M(-29.3%) |
| Sep 2021 | - | $18.31 M(-178.1%) | -$28.54 M(-40.0%) |
| Jun 2021 | - | -$23.44 M(+45.8%) | -$47.58 M(+100.9%) |
| Mar 2021 | - | -$16.08 M(+119.3%) | -$23.68 M(+141.2%) |
| Dec 2020 | -$9.82 M(-61.1%) | -$7.33 M(+906.5%) | -$9.82 M(-65.1%) |
| Sep 2020 | - | -$728.50 K(-259.5%) | -$28.12 M(+2.8%) |
| Jun 2020 | - | $456.80 K(-120.6%) | -$27.36 M(-1.4%) |
| Mar 2020 | - | -$2.21 M(-91.4%) | -$27.76 M(+8.7%) |
| Dec 2019 | -$25.22 M | -$25.64 M(<-9900.0%) | -$25.55 M(<-9900.0%) |
| Sep 2019 | - | $29.60 K(-50.3%) | $89.20 K(+49.7%) |
| Jun 2019 | - | $59.60 K | $59.60 K |
FAQ
- What is 180 Life Sciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for 180 Life Sciences?
- What is 180 Life Sciences annual EBIT year-on-year change?
- What is 180 Life Sciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for 180 Life Sciences?
- What is 180 Life Sciences quarterly EBIT year-on-year change?
- What is 180 Life Sciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for 180 Life Sciences?
- What is 180 Life Sciences TTM EBIT year-on-year change?
What is 180 Life Sciences annual earnings before interest & taxes?
The current annual EBIT of ATNF is -$22.24 M
What is the all time high annual EBIT for 180 Life Sciences?
180 Life Sciences all-time high annual earnings before interest & taxes is -$9.82 M
What is 180 Life Sciences annual EBIT year-on-year change?
Over the past year, ATNF annual earnings before interest & taxes has changed by +$17.40 M (+43.90%)
What is 180 Life Sciences quarterly earnings before interest & taxes?
The current quarterly EBIT of ATNF is -$823.10 K
What is the all time high quarterly EBIT for 180 Life Sciences?
180 Life Sciences all-time high quarterly earnings before interest & taxes is $18.31 M
What is 180 Life Sciences quarterly EBIT year-on-year change?
Over the past year, ATNF quarterly earnings before interest & taxes has changed by +$230.20 K (+21.86%)
What is 180 Life Sciences TTM earnings before interest & taxes?
The current TTM EBIT of ATNF is -$3.07 M
What is the all time high TTM EBIT for 180 Life Sciences?
180 Life Sciences all-time high TTM earnings before interest & taxes is $23.87 M
What is 180 Life Sciences TTM EBIT year-on-year change?
Over the past year, ATNF TTM earnings before interest & taxes has changed by +$15.47 M (+83.42%)